New state generics complaint is tougher on execs
Forty four states have sued 20 of the largest generic drugmakers – particularly targeting Teva Pharmaceuticals – alleging price manipulation, restraint of trade and other antitrust violations.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10